Given that ePrescribing is one of the most significant changes to our industry, this is not surprising.
So we decided to host a session that's 100% dedicated to Q&A and pulled together a panel of industry experts:
We were so pleased to have such an experienced and diverse panel of experts ready to answer your questions.
*Andrew has no direct association with MedAdvisor and contributes to this Q&A session consistent with the Agency’s support for all software providers participating in electronic prescribing.
Share with your friends